| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| osimertinib mechanism of action video | 0.53 | 0.8 | 3783 | 7 | 37 |
| osimertinib | 1.75 | 0.2 | 7077 | 77 | 11 |
| mechanism | 1.11 | 1 | 431 | 76 | 9 |
| of | 0.88 | 0.7 | 3047 | 7 | 2 |
| action | 1.62 | 0.3 | 4927 | 29 | 6 |
| video | 0.47 | 1 | 3551 | 39 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| osimertinib mechanism of action video | 1.77 | 0.2 | 8163 | 83 |
| osimertinib mechanism of resistance | 1.31 | 0.3 | 1288 | 67 |
| osimertinib duration of action | 0.71 | 0.4 | 1201 | 45 |
| how does osimertinib work | 1.69 | 0.6 | 5378 | 56 |
| resistance mechanisms to osimertinib | 0.38 | 0.5 | 1496 | 87 |
| osimertinib mecanismo de accion | 1.27 | 0.8 | 1388 | 15 |
| osimertinib time to response | 0.22 | 0.1 | 4561 | 77 |
| what is osimertinib used for | 0.15 | 0.6 | 1299 | 47 |
| osimertinib plasma protein binding | 0.62 | 0.1 | 323 | 93 |
| primary resistance to osimertinib | 0.9 | 1 | 4073 | 96 |
| osimertinib + savolitinib | 0.46 | 0.4 | 2524 | 76 |
| is osimertinib an immunosuppressant | 0.69 | 0.2 | 4091 | 63 |
| osimertinib summary basis of approval | 1.74 | 0.8 | 5069 | 81 |
| osimertinib_1919 | 0.6 | 0.8 | 2841 | 41 |
| is osimertinib a chemotherapy drug | 1.79 | 0.1 | 8741 | 3 |
| is osimertinib a chemotherapy | 1.81 | 1 | 6668 | 82 |
| osimertinib potential side effect | 0.49 | 0.4 | 945 | 20 |
| osimertinib side effects macmillan | 1.7 | 1 | 7964 | 49 |
| osimertinib para que sirve | 0.81 | 0.8 | 6863 | 1 |
